Anna Kane
About Anna Kane
Anna Kane serves as the Associate Director of Neurodegeneration Initiatives at the Broad Institute of MIT and Harvard, where she facilitates research collaborations and supports large-scale studies on neurodegeneration and Alzheimer's Disease. She has a strong academic background in neuroscience, holding a PhD from Brown University and extensive experience in research and project management.
Current Role at Broad Institute
Anna Kane serves as the Associate Director of Neurodegeneration Initiatives at the Broad Institute of MIT and Harvard. She has held this position since 2023 in Cambridge, Massachusetts. In her role, she facilitates research collaborations between MIT and Harvard, focusing on advancing the understanding of neurodegeneration. Her work supports large-scale collaborative research initiatives that investigate the neuroimmune underpinnings of Alzheimer's Disease.
Previous Experience at National Institutes of Health
Prior to her current role, Anna Kane worked at the National Institutes of Health as a Graduate Student from 2009 to 2014. During her five years there, she gained significant experience in neuroscience research, which laid the foundation for her future endeavors in the field.
Work History at Forefront International Corporation
Anna Kane was employed as a Project Manager at Forefront International Corporation for one year, from 2017 to 2018. In this role, she managed various projects, contributing her expertise in neuroscience and project management.
Educational Background in Neuroscience
Anna Kane has a strong educational background in neuroscience. She earned her Bachelor of Arts degree from Vassar College, studying Neuroscience from 2003 to 2007. She then pursued a PhD in Neuroscience at Brown University, completing her studies from 2009 to 2014.
Postdoctoral Research Fellowship at University of Michigan
After completing her PhD, Anna Kane served as a Postdoctoral Research Fellow at the University of Michigan Medical School from 2015 to 2017. This two-year position allowed her to further develop her research skills and deepen her knowledge in neurodegeneration.